INDEMNIFICATION AGREEMENTIndemnification Agreement • March 8th, 2024 • EyePoint Pharmaceuticals, Inc. • Laboratory analytical instruments
Contract Type FiledMarch 8th, 2024 Company IndustryThis Indemnification Agreement (“Agreement”) is made as of - by and between EyePoint Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and - (“Indemnitee”). This Agreement supersedes and replaces any and all previous agreements between the Company and Indemnitee covering the subject matter of this Agreement.
CONSULTING AGREEMENT between EYEPOINT PHARMACEUTICALS US, INC. and John Landis, PhDConsulting Agreement • March 8th, 2024 • EyePoint Pharmaceuticals, Inc. • Laboratory analytical instruments • Massachusetts
Contract Type FiledMarch 8th, 2024 Company Industry JurisdictionTHIS Consulting Agreement (the “Agreement”), effective as of December 18, 2023 (the “Effective Date”), is entered into between John Landis, PhD (“Consultant”) and EyePoint Pharmaceuticals US, Inc. (“EyePoint”), a corporation organized under the laws of the State of Delaware.